Tactic Pharma, LLC



About us

Tactic Pharmaceuticals acquires and develops pre-clinical and clinical stage compounds. Tactic currently has two development stage compounds in its portfolio: ATN-161 and ATN-658.  


Contact Information

info@tacticpharma.com